Χώρα: Μάλτα
Γλώσσα: Αγγλικά
Πηγή: Medicines Authority
OLANZAPINE
Actavis Group PTC ehf
N05AH03
OLANZAPINE
FILM-COATED TABLET
OLANZAPINE 15 mg
POM
PSYCHOLEPTICS
Authorised
2008-03-20
1 PACKAGE LEAFLET: INFORMATION FOR THE USER OLANZAPIN ACTAVIS 2.5 MG FILM-COATED TABLETS OLANZAPIN ACTAVIS 5 MG FILM-COATED TABLETS OLANZAPIN ACTAVIS 7.5 MG FILM-COATED TABLETS OLANZAPIN ACTAVIS 10 MG FILM-COATED TABLETS OLANZAPIN ACTAVIS 15 MG FILM-COATED TABLETS OLANZAPIN ACTAVIS 20 MG FILM-COATED TABLETS Olanzapine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Olanzapin Actavis is and what it is used for 2. What you need to know before you take Olanzapin Actavis 3. How to take Olanzapin Actavis 4. Possible side effects 5. How to store Olanzapin Actavis 6. Contents of the pack and other information 1. WHAT OLANZAPIN ACTAVIS IS AND WHAT IT IS USED FOR Olanzapin Actavis contains the active substance olanzapine. Olanzapin Actavis belongs to a group of medicines called antipsychotics and is used to treat the following conditions: - Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn. People with this disease may also feel depressed, anxious or tense. - Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria. Olanzapin Actavis has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE OLANZAPIN ACTAVIS DO NOT TAKE OLANZAPIN ACTAVIS - if you are allergic to olanzapine or any of the other ingredients of this medicine (listed Διαβάστε το πλήρες έγγραφο
Page 1 of 17 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Olanzapin Actavis 2.5 mg film-coated tablets Olanzapin Actavis 5 mg film-coated tablets Olanzapin Actavis 7.5 mg film-coated tablets Olanzapin Actavis 10 mg film-coated tablets Olanzapin Actavis 15 mg film-coated tablets Olanzapin Actavis 20 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg olanzapine. Excipients with known effect: 2.5 mg film-coated tablet contains 58.3 mg lactose anhydrous. 5 mg film-coated tablet contains 116.6 mg lactose anhydrous. 7.5 mg film-coated tablet contains 174.9 mg lactose anhydrous. 10 mg film-coated tablet contains 233.2 mg lactose anhydrous. 15 mg film-coated tablet contains 228.2 mg lactose anhydrous. 20 mg film-coated tablet contains 304.3 mg lactose anhydrous. Contains soya lechitin. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Film-coated tablet 2.5 mg: Round, biconvex, white film-coated tablet 6 mm in diameter, marked with “O” on one side. Film-coated tablet 5 mg: Round, biconvex, white film-coated tablet 8 mm in diameter, marked with “O1” on one side. Film-coated tablet 7.5 mg: Round, biconvex, white film-coated tablet 9 mm in diameter, marked with “O2” on one side. Film-coated tablet 10 mg: Round, biconvex, white film-coated tablet 10 mm in diameter, marked with “O3” on one side. Film-coated tablet 15 mg: Oval, biconvex, light blue film-coated tablet 7.35 x 13.35 mm in diameter, marked with “O” on one side. Film-coated tablet 20 mg: Oval, biconvex, light pink film-coated tablet 7.5 x 14.5 mm in diameter, marked with “O” on one side. Page 2 of 17 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Adults Olanzapine is indicated for the treatment of schizophrenia. Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Olanzapine is indica Διαβάστε το πλήρες έγγραφο